XML 187 R154.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Share (Details)
3 Months Ended
Sep. 24, 2018
shares
Sep. 19, 2018
Mar. 31, 2019
shares
Sep. 18, 2018
shares
Dec. 31, 2017
shares
Subsidiary, Sale of Stock [Line Items]          
Stock split ratio   2,932,900      
Antidilutive shares not included in calculating diluted earnings per share     200,000    
IPO          
Subsidiary, Sale of Stock [Line Items]          
Number of shares issued 72,335,000        
Elanco | Lilly          
Subsidiary, Sale of Stock [Line Items]          
Common shares outstanding       100 293,290,000